Medicine Overview of Onriva 75 75mcg Capsule
Onriva 75 is used for the treatment of asthma and chronic obstructive pulmonary disorder(COPD) ,a lung disorder in which flow of air to the lung is blocked. It helps in relaxing the muscles of the air passages, thus widening it and making it easier to breathe.
Onriva 75 is only for the inhalational purpose, so do not swallow the capsule. The first dose is given under medical supervision to prevent the side effects happen during first use. For better results, it is suggested to take it at the same time every day. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. You should take this medicine for as long as it is prescribed for you. It does not prevent the already started breathing trouble or COPD attack, hence always carry your medical inhaler with you for an emergency. Always use the mouthpiece to come along with the package.
The most common side effects of this medicine include cold-like symptoms, runny nose, headache, cough, and dizziness. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. Generally, it is advised to avoid alcohol while on treatment as it may affect heart rate.
Before taking this medicine, let your doctor know if you have a heart problem, or have high blood pressure or diabetes or thyroid. Inform your doctor if you are pregnant or breastfeeding. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works.
- Asthma
- Chronic obstructive pulmonary disease (COPD)
- Runny nose
- Headache
- Cough
- Dizziness
-
This medicine is for inhalation only. The tablet should not be swallowed.
-
It should be taken at the same time each day.
-
It does not work right away and should not be used to relieve sudden breathing problems.
-
Take the first dose of this medicine under medical supervision as it may cause wheezing or tightening of the airways (bronchospasm) immediately after using.
-
Dry mouth may occur as a side effect. Frequent mouth rinses, good oral hygiene, increased water intake and sugarless candy may help.
Inhalation
Maintenance therapy in chronic obstructive pulmonary disease
Adult: As inhal cap: Inhale 75-150 mcg once daily using inhaler.
Max: 300 mcg once daily.
Hepatic impairment
No dose adjustment is required for patients with mild and moderate hepatic impairment.
There are no data available for use of Onbrez Breezhaler in patients with severe hepatic impairment.
Renal impairment
No dose adjustment is required for patients with renal impairment.
Not intended for treatment of asthma and acute deterioration of COPD. Patient w/ acutely deteriorating COPD, thyrotoxicosis, seizure disorders, DM, hypokalaemia, CV disorders esp coronary insufficiency, cardiac arrhythmias or HTN. Pregnancy and lactation.
Lactation: Unknown whether distributed in human breast milk; use caution
>10%
Post-inhalation cough (24% compared with 7% on placebo)
1-10%
Cough (6.5%),Nasopharyngitis (5.3%),Headache (5.1%),Nausea (2.4%),Oropharyngeal pain (2.2%)
Potentially Fatal: Asthma-related deaths.
Reviews
Clear filtersThere are no reviews yet.